NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2025.
Publication
, Journal Article
Abu-Rustum, NR; Campos, SM; Amarnath, S; Arend, R; Barber, E; Bradley, K; Brooks, R; Chino, J; Chon, HS; Crispens, MA; Damast, S; Fisher, CM ...
Published in: J Natl Compr Canc Netw
August 2025
The NCCN Guidelines for Uterine Neoplasms provide recommendations for diagnostic workup, clinical staging, and treatment options for patients with endometrial cancer and uterine sarcoma. The NCCN Cervical Uterine Panel meets at least annually to review comments from reviewers within their institutions; examine relevant new data from publications, abstracts, and recent FDA approvals; and reevaluate and update recommendations. These NCCN Guidelines Insights summarize the panel's deliberations on the new FIGO 2023 staging system and updates on the new systemic therapy recommendations for the management of endometrial cancer.
Duke Scholars
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
August 2025
Volume
23
Issue
8
Start / End Page
284 / 291
Location
United States
Related Subject Headings
- Uterine Neoplasms
- Oncology & Carcinogenesis
- Neoplasm Staging
- Humans
- Female
- Endometrial Neoplasms
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Abu-Rustum, N. R., Campos, S. M., Amarnath, S., Arend, R., Barber, E., Bradley, K., … Sambandam, V. (2025). NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2025. J Natl Compr Canc Netw, 23(8), 284–291. https://doi.org/10.6004/jnccn.2025.0038
Abu-Rustum, Nadeem R., Susana M. Campos, Sudha Amarnath, Rebecca Arend, Emma Barber, Kristin Bradley, Rebecca Brooks, et al. “NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2025.” J Natl Compr Canc Netw 23, no. 8 (August 2025): 284–91. https://doi.org/10.6004/jnccn.2025.0038.
Abu-Rustum NR, Campos SM, Amarnath S, Arend R, Barber E, Bradley K, et al. NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2025. J Natl Compr Canc Netw. 2025 Aug;23(8):284–91.
Abu-Rustum, Nadeem R., et al. “NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2025.” J Natl Compr Canc Netw, vol. 23, no. 8, Aug. 2025, pp. 284–91. Pubmed, doi:10.6004/jnccn.2025.0038.
Abu-Rustum NR, Campos SM, Amarnath S, Arend R, Barber E, Bradley K, Brooks R, Chino J, Chon HS, Crispens MA, Damast S, Fisher CM, Frederick P, Gaffney DK, Gaillard S, Giuntoli R, Glaser S, Howitt BE, Landrum L, Lea J, Lee N, Mantia-Smaldone G, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Nieto K, Nwachukwu C, Podoll M, Rodabaugh K, Salani R, Schorge J, Schuetze S, Siedel J, Sisodia R, Soliman P, Ueda S, Urban R, Wyse E, McMillian N, Sambandam V. NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2025. J Natl Compr Canc Netw. 2025 Aug;23(8):284–291.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
August 2025
Volume
23
Issue
8
Start / End Page
284 / 291
Location
United States
Related Subject Headings
- Uterine Neoplasms
- Oncology & Carcinogenesis
- Neoplasm Staging
- Humans
- Female
- Endometrial Neoplasms
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis